| 糖耐量减低与心血管疾病及阿卡波糖作用 |
| |
| 引用本文： | 张倩,吴国亭.糖耐量减低与心血管疾病及阿卡波糖作用[J].国际内分泌代谢杂志,2006,29(1):13-16. |
| |
| 作者姓名： | 张倩 吴国亭 |
| |
| 作者单位： | 上海市第十人民医院内分泌科,200072; |
| |
| 摘 要： | Impaired glucose tolerance(IGT) is a clinical state between normal and abnormal glucose metabolism with increased risk of cardiovascular disease. Its mechanism mainly related to insulin resistance, oxidative stress ,blood hypercoagulability, inflammatory response ,as well as related lipotoxieity. α-glucosidase inhibitor acarbose is safe and effective to reduce postprandial hyperglycemia, and has been approved for the treatment of patients with IGT. A growing number of studies have shown that acarbose also has cardiovascular benefit.
|
| 关 键 词： | α-葡萄糖苷酶抑制剂 阿卡波糖 糖耐量减低 心血管疾病 α-glucosidase inhibitor |
Impaired glucose tolerance and cardiovascular disease and progress of acarbose |
| |
| ZHANG Qian,WU Guo-ting.Impaired glucose tolerance and cardiovascular disease and progress of acarbose[J].International JOurnal of Endocrinology and Metabolism,2006,29(1):13-16. |
| |
| Authors: | ZHANG Qian WU Guo-ting |
| |
| Abstract: | |
| |
| Keywords: | AcarboseImpaired glucose toleranceCardiovascular disease |
|
|
